Japanese Life Sciences Stock News

Sharp (TSE:6753) shares have shown a modest recovery over the past month, climbing about 1% after several weeks of muted trading. Investors have taken note, weighing recent performance against longer-term returns and the company's latest financial disclosures. See our latest analysis for Sharp. While Sharp's shares have bounced back modestly in the last month, the bigger story is how momentum has shifted over the past quarter. The 31.1% 90-day share price return suggests renewed optimism,...

NEC (TSE:6701) shares have seen a mix of movements recently, catching the attention of investors curious about the company’s current valuation. Over the past month, the stock has steadily climbed, supported by consistent business fundamentals. See our latest analysis for NEC. Momentum has clearly been building for NEC this year, with the share price up 78.44% year-to-date and a stellar 77.14% total shareholder return over the last twelve months. While there have been short-term ebbs and...

Riso Kyoiku Group (TSE:4714) is forecasting robust expansion, with earnings projected to grow 15.88% per year and revenue expected to rise 5.9% annually, both outpacing Japan’s broader market trends. Still, net profit margin slipped to 4.2% from 5.3% last year, snapping the five-year stretch of 6% annual earnings growth and introducing some near-term margin pressure. As growth forecasts stay positive and the stock’s valuation signals both premium pricing and discounted cash flow upside,...

Chiba Bank (TSE:8331) has just unveiled plans to launch a substantial share repurchase program, targeting up to 12 million shares, which represents about 1.7% of its total issued share capital by December 2025. See our latest analysis for Chiba Bank. Chiba Bank’s latest buyback announcement comes following a strong run for shareholders, with a 33.7% total return over the past year and an impressive 204% over five years. This suggests growing market confidence in its long-term potential...

Between July 1 and September 30, 2025, Mitsubishi completed its previously announced share buyback, repurchasing 73,862,500 shares, or 1.92% of outstanding shares, for ¥230,846 million, bringing the total under the program to 213,749,711 shares bought for ¥578.16 billion. This sizeable buyback, equal to 5.44% of the company’s shares, represents a substantial capital allocation toward shareholder returns and may signal management’s confidence in future earnings. Now, we'll explore how...

Mr Max Holdings (TSE:8203) posted a 7.9% rise in profits for the past year, a notable reversal from its 5-year average annual decline of 4%. Net profit margins inched up to 2.1%, just above last year’s 2%, and the quality of reported earnings remains high. With shares trading at a price-to-earnings ratio of 9.1x, well below both peer and industry averages, investors will be weighing these attractively priced results against a number of flagged risks, including ongoing financial and dividend...

Astellas Pharma (TSE:4503) is back in the spotlight as it prepares to share new results in both oncology and ophthalmology at major medical conferences. The recent reimbursement for VYLOY in Canada also broadens potential commercial returns. See our latest analysis for Astellas Pharma. With fresh reimbursement wins for VYLOY and major new oncology data heading to ESMO, momentum around Astellas Pharma is building. While the 90-day share price return stands at 15.25%, recent performance has...

Sony Financial Group (TSE:8729) has captured attention following its announcement of a major share buyback initiative, along with recent shifts in its index status. These moves are sparking fresh conversations about the stock’s overall appeal. See our latest analysis for Sony Financial Group. It’s been a volatile few weeks for Sony Financial Group, with a flurry of share buyback announcements and rapid shifts in its index listings sending mixed signals to investors. After a tough year-to-date...

In the past week, INPEX Corporation announced it acquired 4,788,600 of its own shares through market purchases on the Tokyo Stock Exchange, as part of a buyback program targeting up to 50 million shares by the end of 2025. This ongoing share repurchase initiative highlights INPEX’s active capital management and its intention to potentially enhance shareholder value amid an evolving energy sector. We’ll examine how INPEX’s renewed commitment to buybacks could impact its investment narrative...

OSG (TSE:6136) continues to draw investor interest as it trends higher over the past month, not because of a fresh headline event but due to its solid performance and steady growth metrics. See our latest analysis for OSG. Momentum has clearly been building for OSG, with the share price delivering a 7.99% return over the past month and extending to a hefty 21.71% return year-to-date. Even more impressively, OSG's total shareholder return of nearly 30% over the past year highlights how...

Kura Oncology and Kyowa Kirin recently announced the initiation of two global, randomized Phase 3 clinical trials evaluating ziftomenib, an investigational oral menin inhibitor, in combination with standard therapies for newly diagnosed patients with specific genetic mutations in acute myeloid leukemia (AML). Ziftomenib is currently the only menin inhibitor to receive Breakthrough Therapy Designation from the FDA for relapsed or refractory NPM1-mutated AML, underscoring its potential to...

Nippon Shokubai (TSE:4114) just wrapped up its latest share buyback initiative, acquiring more than 2.8 million shares from late July through September. This move often draws attention from investors who are considering longer-term value. See our latest analysis for Nippon Shokubai. This buyback concludes at a time when Nippon Shokubai’s share price has swung lower in recent weeks. However, the three-year total shareholder return stands at more than 53%, suggesting that the company’s steady...

Matsuya (TSE:8237) recorded a net profit margin of 0.9% for the twelve months ending August 31, 2025, a sharp drop from 7.2% the previous year. Profitability was hit by a one-off loss of ¥1.4 billion, despite the company’s average earnings growth of 41.4% per year over the past five years. Meanwhile, Matsuya’s shares currently trade at a Price-to-Sales ratio of 1.8x, well above both the industry and peer averages. This could weigh on investor sentiment as margins compress. See our full...

Marubeni Corp. recently established Marubeni Power Trading, a new joint venture with its subsidiary SmartestEnergy Ltd., to expand into Japan’s liberalized power market through spot and futures trading of electricity and fuels. This move highlights Marubeni’s intent to leverage growing power demand from artificial intelligence and data center expansion, as well as the region’s increasingly active derivatives markets. We’ll explore how establishing Marubeni Power Trading supports the...

Nippon BS Broadcasting (TSE:9414) reported a net profit margin of 11.4%, just below last year’s 11.9%, while earnings have been on a downward trend, falling 4.9% per year over the past five years and showing another decline in the most recent period. Despite these headwinds, the stock’s Price-To-Earnings ratio is 13x, which stands lower than peers (15.7x) and the broader Japanese media sector (17.7x), with shares trading at ¥981, well under the fair value estimate of ¥2,616.13. The results...

With its stock down 10% over the past three months, it is easy to disregard Hamamatsu Photonics K.K (TSE:6965). We...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Kajima fair value estimate is JP¥5,246 Kajima's JP¥4,450 share...

Mabuchi Motor Co., Ltd. recently completed a buyback of 2,839,400 shares for ¥6,218.79 million and established a new wholly owned subsidiary, Mabuchi Motor Engineering Co., Ltd., to enhance its design and manufacturing capabilities. By investing in in-house engineering capacity and completing its share repurchase program, the company aims to support future product diversification and integration of past acquisitions. We'll explore how expanding in-house design and manufacturing through...

Japaniace Co.,Ltd. ( TSE:9558 ) will increase its dividend from last year's comparable payment on the 25th of February...

When close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 14x, you may consider Fujimi...

LIKE, Inc.'s ( TSE:2462 ) investors are due to receive a payment of ¥30.00 per share on 10th of February. This will...

The board of CL Holdings Inc. ( TSE:4286 ) has announced that it will be paying its dividend of ¥16.00 on the 31st of...

The board of Satori Electric Co., Ltd. ( TSE:7420 ) has announced that it will pay a dividend on the 16th of February...